Erica Elizabeth Marsh, MD, MSCI, FACOG

Dr. Marsh is a Professor of Obstetrics and Gynecology at the University of Michigan Medical School and Chief of the Division of Reproductive Endocrinology and Infertility.

She attended Harvard College where she graduated magna cum laude followed by Harvard Medical School where she graduated cum laude in 2001. She then completed her residency at the Integrated OBGYN Residency at the Brigham and Women’s Hospital and Massachusetts General Hospital in 2005. After residency, Dr. Marsh completed a Reproductive Endocrinology and Infertility fellowship at Northwestern University. During this time, Dr. Marsh also earned a Master of Science in Clinical Investigation (MSCI) from Northwestern University. After completing fellowship in 2008, Dr. Marsh joined the faculty at Northwestern University’s Feinberg School of Medicine.

In 2016, Dr. Marsh joined the U of M family. She is the founder and Director of the onWHARD collaborative, a group dedicated to women’s health and reproductive disparities research, education, and advocacy. In this capacity, she leads several large research studies including SOAR, a project investigating ovarian aging in African American women, and ELLAS, a cohort study designed to help health care providers better understand reproductive health conditions affecting the Latina/Latinx community.

Dr. Marsh is also a committed community advocate. She builds bridges between community organizations and academia with community-based participatory research initiatives that have led to funding, publications, and awards.

Dr. Marsh specializes in infertility, uterine fibroids, abnormal uterine bleeding, PCOS, ovarian reserve, amenorrhea, and irregular periods.

University of Michigan Health participates with most health insurance plans.

Dr. Marsh's research focuses on uterine fibroids and reproductive health disparities. She seeks to understand the challenges of fibroids from a 360 degree perspective by investigating addressing their pathophysiology, their epidemiology, and clinical impact through a patient-centered lens. From a basic science perspective, she is interested in the extracellular matrix (ECM) and understanding the role of microRNA in the development of fibroid ECM. Clinically, she is interested in the interplay between obesity and glucose dysregulation and fibroid development. From the patient perspective, she seeks to understand drivers of patient knowledge around fibroids, as well as factors that guide patient outcomes and decision-making around treatment.

Dr. Marsh has received millions of dollars in funding to support her research and has published significantly in the area of fibroids and reproductive health disparities in women’s health. Her work is currently funded by the NICHD, NIMHD, and PCORI. In 2015, she was recently named the 2015 Ira and Ester Rosenwaks New Investigator of the Year by the American Society of Reproductive Medicine for her research on fibroids and health disparities.